ElixirCurozole

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: ElixirCurozole
Generic name: CLOTRIMAZOLE
Manufacturer: ELIXIR HEALTHCARE USA, LLC.
Product type: HUMAN OTC DRUG
SPL set ID: 0c468a9e-d092-4704-b742-92ecd9918209
SPL ID: 46da2930-c495-ef32-e063-6394a90a99ee
Version: 1
Effective date: 2025-12-26
Source export date: 2026-10-27
Source partition: 12
Source file: https://download.open.fda.gov/drug/label/drug-label-0012-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-27/977776a6cc37ec1c77259da8a93ae161850a3aa120341096e5a03428b84d016b/drug-label-0012-of-0014.json.zip
Source manifest SHA-256: 6be3667a3beefe6c0ead4c723ea963050533a2bc725a8044d58b07d18b258c55
Import run: 20261027T193451Z
Imported at: 2026-10-27 20:58:49

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M015	openfda.application_number
brand name		ElixirCurozole	openfda.brand_name
generic name		CLOTRIMAZOLE	openfda.generic_name
manufacturer name		ELIXIR HEALTHCARE USA, LLC.	openfda.manufacturer_name
ndc	package	84546-0003-1	openfda.package_ndc
ndc	product	84546-0003	openfda.product_ndc
ndc11	package	84546000301	derived:openfda.package_ndc
rxcui		309367	openfda.rxcui
spl id		46da2930-c495-ef32-e063-6394a90a99ee	id
spl set id		0c468a9e-d092-4704-b742-92ecd9918209	set_id
unii		G07GZ97H65	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only When using this product avoid contact with eyes Stop use and ask a doctor if • irritation occurs; • there is no improvement within 4 weeks (for athlete's foot or ringworm) or 2 weeks (for jock itch); If swallowed, get medical help or contact a Poison Control Center right away

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.